Correlation Between Biotechnology Ultrasector and Franklin Emerging

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Franklin Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Franklin Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Franklin Emerging Market, you can compare the effects of market volatilities on Biotechnology Ultrasector and Franklin Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Franklin Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Franklin Emerging.

Diversification Opportunities for Biotechnology Ultrasector and Franklin Emerging

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Biotechnology and Franklin is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Franklin Emerging Market in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Emerging Market and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Franklin Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Emerging Market has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Franklin Emerging go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Franklin Emerging

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to generate 11.12 times more return on investment than Franklin Emerging. However, Biotechnology Ultrasector is 11.12 times more volatile than Franklin Emerging Market. It trades about 0.02 of its potential returns per unit of risk. Franklin Emerging Market is currently generating about 0.23 per unit of risk. If you would invest  6,119  in Biotechnology Ultrasector Profund on September 12, 2024 and sell it today you would earn a total of  444.00  from holding Biotechnology Ultrasector Profund or generate 7.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Franklin Emerging Market

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Franklin Emerging Market 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Emerging Market are ranked lower than 20 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Franklin Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Ultrasector and Franklin Emerging Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Franklin Emerging

The main advantage of trading using opposite Biotechnology Ultrasector and Franklin Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Franklin Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Emerging will offset losses from the drop in Franklin Emerging's long position.
The idea behind Biotechnology Ultrasector Profund and Franklin Emerging Market pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets